Cited by 208RNA Interference and Gene DeliveryRNA and protein synthesis mechanismsRNA Research and Splicing

The DOI matches its Crossref record; 254 of the 257 references it cites were found in a registry or an index.

Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine

Kwon, Hyokyoung, Kim, Minjeong, Seo, Yunmi, Moon, Yae Seul, Lee, Hwa Jeong, Lee, Kyuri, Lee, Hyukjin·2018·Biomaterials

DOI 10.1016/j.biomaterials.2017.11.034

Open this paper in CoChat — free account

Abstract

The field of gene therapy has evolved over the past two decades after the first introduction of nucleic acid drugs, such as plasmid DNA (pDNA). With the development of in vitro transcription (IVT) methods, synthetic mRNA has become an emerging class of gene therapy. IVT mRNA has several advantages over conventional pDNA for the expression of target proteins. mRNA does not require nuclear localization to mediate protein translation. The intracellular process for protein expression is much simpler and there is no potential risk of insertion mutagenesis. Having these advantages, the level of protein expression is far enhanced as comparable to that of viral expression systems. This makes IVT mRNA a powerful alternative gene expression system for various applications in regenerative medicine. In this review, we highlight the synthesis and preparation of IVT mRNA and its therapeutic applications. The article includes the design and preparation of IVT mRNA, chemical modification of IVT mRNA, and therapeutic applications of IVT mRNA in cellular reprogramming, stem cell engineering, and protein replacement therapy. Finally, future perspectives and challenges of IVT mRNA are discussed.

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2017.11.034

Cites

254 of 254 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA
Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930
Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins
Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.005 · Cited by 1,788
Synonymous but not the same: the causes and consequences of codon bias
Plotkin, J. B., & Kudla, G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2899 · Cited by 1,722
Induced pluripotent stem cells generated without viral integration
Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K. (2008) · Science · doi:10.1126/science.1162494 · Cited by 1,683
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments
Lee, K., Silva, E. A., & Mooney, D. J. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2010.0223 · Cited by 1,424
Self-citation
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Li, Q., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,376
Leukocyte Migration into Inflamed Tissues
Nourshargh, S., & Alon, R. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.008 · Cited by 1,236
At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells
Kozak, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90418-9 · Cited by 1,182
Heart repair by reprogramming non-myocytes with cardiac transcription factors
Song, K., Nam, Y., Luo, X., Qi, X., Tan, W. H., Huang, G. N., Acharya, A., Smith, C. L., Tallquist, M. D., Neilson, E. G., et al. (2012) · Nature · doi:10.1038/nature11139 · Cited by 1,162
Protein drug stability: a formulation challenge
Frøkjær, S., & Otzen, D. E. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1695 · Cited by 1,116
mRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Regenerative medicine: Current therapies and future directions
Mao, A. S., & Mooney, D. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508520112 · Cited by 998
Untranslated regions of mRNAs.
(2002) · Genome biology · doi:10.1186/gb-2002-3-3-reviews0004 · Cited by 987
mRNA capping: biological functions and applications
Ramanathan, A., Robb, G. B., & Chan, S. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw551 · Cited by 961
Modified mRNA vaccines protect against zika virus infection
Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
Karikó, K., Muramatsu, H., Ludwig, J., & Weissman, D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr695 · Cited by 898
A decade of transcription factor-mediated reprogramming to pluripotency
Takahashi, K., & Yamanaka, S. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.8 · Cited by 894
Therapeutic antibodies for autoimmunity and inflammation
Chan, A. C., & Carter, P. J. (2010) · Nature reviews. Immunology · doi:10.1038/nri2761 · Cited by 846
Basics and Recent Advances in Peptide and Protein Drug Delivery
Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 771
Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration
Jopling, C., Boué, S., & Belmonte, J. C. I. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3043 · Cited by 750
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733
Improvement in outcomes of clinical islet transplantation: 1999–2010
Barton, F. B., Rickels, M. R., Alejandro, R., Hering, B. J., Wease, S., Naziruddin, B., Oberholzer, J., Odorico, J. S., Garfinkel, M. R., Levy, M., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0063 · Cited by 725
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
Oberli, M. A., Reichmuth, A. M., Dorkin, J. R., Mitchell, M. J., Fenton, O. S., Jaklenec, A., Anderson, D. G., Langer, R., & Blankschtein, D. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b03329 · Cited by 719
N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice
Andries, O., Mc Cafferty, S., De Smedt, S. C., Weiss, R., Sanders, N. N., & Kitada, T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.051 · Cited by 701
Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples
Masuda, N., Ohnishi, T., Kawamoto, S., Monden, M., & Okubo, K. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.22.4436 · Cited by 683
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
Anderson, B. R., Muramatsu, H., Nallagatla, S. R., Bevilacqua, P. C., Sansing, L. H., Weissman, D., & Karikó, K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq347 · Cited by 682
The mRNA 5′ cap-binding protein eIF4E and control of cell growth
Sonenberg, N., & Gingras, A. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80150-6 · Cited by 673
Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction
Zangi, L., Lui, K. O., von Gise, A., Ma, Q., Ebina, W., Ptaszek, L. M., Später, D., Xu, H., Tabebordbar, M., Gorbatov, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2682 · Cited by 646
Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells
Holtkamp, S., Kreiter, S., Selmi, A., Simon, P., Koslowski, M., Huber, C., Türeci, O., & Sahin, U. (2006) · Blood · doi:10.1182/blood-2006-04-015024 · Cited by 625
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
Nakamura, K., Ito, Y., Kawano, Y., Kurozumi, K., Kobune, M., Tsuda, H., Bizen, A., Honmou, O., Niitsu, Y., & Hamada, H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302276 · Cited by 597
Delivery technologies for genome editing
Yin, H., Kauffman, K. J., & Anderson, D. G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.280 · Cited by 597
Recognition of cap structure in splicing in vitro of mRNA precursors
Konarska, M. M., Padgett, R. A., & Sharp, P. A. (1984) · Cell · doi:10.1016/0092-8674(84)90268-x · Cited by 588
Maturation of Human Embryonic Stem Cell–Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in Mice
Rezania, A., Bruin, J. E., Riedel, M. J., Mojibian, M., Asadi, A., Xu, J., Gauvin, R., Narayan, K., Karanu, F., O’Neil, J. J., et al. (2012) · Diabetes · doi:10.2337/db11-1711 · Cited by 582
Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells
Rüster, B., Göttig, S., Ludwig, R. J., Bistrian, R., Müller, S., Seifried, E., Gille, J., & Henschler, R. (2006) · Blood · doi:10.1182/blood-2006-05-025098 · Cited by 562
Nucleic-acid therapeutics: basic principles and recent applications
Opalinska, J., & Gewirtz, A. M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd837 · Cited by 535
Essential Role for the dsRNA-Dependent Protein Kinase PKR in Innate Immunity to Viral Infection
Balachandran, S., Roberts, P. C., Brown, L. E., Truong, H., Pattnaik, A. K., Archer, D. R., & Barber, G. N. (2000) · Immunity · doi:10.1016/s1074-7613(00)00014-5 · Cited by 527
Characterization and Functionality of Cell Surface Molecules on Human Mesenchymal Stem Cells
Majumdar, M. K., Keane-Moore, M., Buyaner, D., Hardy, W., Moorman, M. A., McIntosh, K. R., & Mosca, J. D. (2003) · Journal of Biomedical Science · doi:10.1007/bf02256058 · Cited by 527
Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms
Kahvejian, A., Svitkin, Y. V., Sukarieh, R., M'Boutchou, M.-N., & Sonenberg, N. (2005) · Genes & Development · doi:10.1101/gad.1262905 · Cited by 491
Molecular basis of double‐stranded RNA‐protein interactions: structure of a dsRNA‐binding domain complexed with dsRNA
Ryter, J. M., & Schultz, S. C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7505 · Cited by 479
5'-terminal cap structure in eucaryotic messenger ribonucleic acids
Banerjee, A. K. (1980) · Microbiological Reviews · doi:10.1128/mr.44.2.175-205.1980 · Cited by 477
Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
Zhao, Y., Moon, E. K., Carpenito, C., Paulos, C. M., Liu, X., Brennan, A. L., Chew, A., Carroll, R. G., Scholler, J., Levine, B. L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2880 · Cited by 458
Cellular IRES-mediated translation
Komar, A. A., & Hatzoglou, M. (2011) · Cell Cycle · doi:10.4161/cc.10.2.14472 · Cited by 455
Targeted Migration of Mesenchymal Stem Cells Modified With CXCR4 Gene to Infarcted Myocardium Improves Cardiac Performance
Cheng, Z., Ou, L., Zhou, X., Li, F., Jia, X., Zhang, Y., Liu, X., Li, Y., Ward, C. A., Melo, L. G., et al. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300374 · Cited by 440
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial
Alton, E. W. F. W., Stern, M., Farley, R., Jaffé, A., Chadwick, S., Phillips, J., Davies, J. C., Smith, S. N., Browning, J. A., Davies, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06532-5 · Cited by 434
Getting Leukocytes to the Site of Inflammation
Müller, W. A. (2013) · Veterinary Pathology · doi:10.1177/0300985812469883 · Cited by 421
Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system.
Elroy‐Stein, O., Fuerst, T. R., & Moss, B. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6126 · Cited by 405
XRN 5′→3′ exoribonucleases: Structure, mechanisms and functions
Nagarajan, V. K., Jones, C. I., Newbury, S. F., & Green, P. J. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.03.005 · Cited by 395
Gene therapy progress and prospects: non-viral gene therapy by systemic delivery
Li, S.-D., & Huang, L. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302838 · Cited by 392
Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
Guan, S., & Rosenecker, J. (2017) · Gene Therapy · doi:10.1038/gt.2017.5 · Cited by 389
Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
Wood, A. J. J., Lieschke, G. J., & Burgess, A. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270207 · Cited by 373
Advances in Non-Viral DNA Vectors for Gene Therapy
Hardee, C. L., Arevalo-Soliz, L. M., Hornstein, B. D., & Zechiedrich, L. (2017) · Genes · doi:10.3390/genes8020065 · Cited by 369
The role of the 3' untranslated region in post-transcriptional regulation of protein expression in mammalian cells.
Matoulkova, E., Michalova, E., Vojtesek, B., & Hrstka, R. (2012) · RNA Biology · doi:10.4161/rna.20231 · Cited by 357
Untitled work
(2001) · PubMed Central · Cited by 342
Reprogramming Factor Stoichiometry Influences the Epigenetic State and Biological Properties of Induced Pluripotent Stem Cells
Carey, B. W., Markoulaki, S., Hanna, J. H., Faddah, D. A., Buganim, Y., Kim, J., Ganz, K., Steine, E. J., Cassady, J. P., Creyghton, M. P., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.11.003 · Cited by 335
Evidence for selection on synonymous mutations affecting stability of mRNA secondary structure in mammals
Chamary, J., & Hurst, L. D. (2005) · Genome biology · doi:10.1186/gb-2005-6-9-r75 · Cited by 324
Efficient generation of human iPSCs by a synthetic self-replicative RNA
Yoshioka, N., Gros, E., Li, H.-R., Kumar, S., Deacon, D. C., Maron, C., Muotri, A. R., Chi, N. C., Fu, X.-D., Yu, B. D., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.06.001 · Cited by 312
Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
Kreiter, S., Selmi, A., Diken, M., Koslowski, M., Britten, C. M., Huber, C., Türeci, Ö., & Sahin, U. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0699 · Cited by 309
Regulation of liver regeneration by growth factors and cytokines
Böhm, F., Köhler, U. A., Speicher, T., & Werner, S. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000085 · Cited by 285
Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin
Karikó, K., Muramatsu, H., Keller, J. M., & Weissman, D. (2012) · Molecular Therapy · doi:10.1038/mt.2012.7 · Cited by 282
Nucleic acid agonists for Toll‐like receptor 7 are defined by the presence of uridine ribonucleotides
Diebold, S. S., Massacrier, C., Akira, S., Paturel, C., Morel, Y., & Sousa, C. R. E. (2006) · European Journal of Immunology · doi:10.1002/eji.200636617 · Cited by 281
Genetic Disorders of Surfactant Dysfunction
Wert, S. E., Whitsett, J. A., & Nogee, L. M. (2009) · Pediatric and Developmental Pathology · doi:10.2350/09-01-0586.1 · Cited by 280
The identity of the base following the stop codon determines the efficiency of in vivo translational termination in Escherichia coli.
Poole, E. S., Brown, C. M., & Tate, W. P. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb06985.x · Cited by 268
The scavenger mRNA decapping enzyme DcpS is a member of the HIT family of pyrophosphatases
Liu, H., Rodgers, N. D., Jiao, X., & Kiledjian, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf448 · Cited by 267
SDF-1α/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model
Wang, Y., Deng, Y., & Zhou, G. (2008) · Brain Research · doi:10.1016/j.brainres.2007.11.068 · Cited by 266
Novel “anti-reverse” cap analogs with superior translational properties
Jemielity, J., Fowler, T. E., Zuberek, J., Stȩpiński, J., Lewdorowicz, M., Niedźwiecka-Kornaś, A., Stolarski, R., Darżynkiewicz, E., & Rhoads, R. E. (2003) · RNA · doi:10.1261/rna.5430403 · Cited by 263
An mRNA Stability Complex Functions with Poly(A)-Binding Protein To Stabilize mRNA In Vitro
Wang, Z., Day, N., Trifillis, P., & Kiledjian, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4552 · Cited by 262
Engineering mesenchymal stem cells for regenerative medicine and drug delivery
Park, J. S., Suryaprakash, S., Lao, Y., & Leong, K. W. (2015) · Methods · doi:10.1016/j.ymeth.2015.03.002 · Cited by 252
Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors
Yakubov, E., Rechavi, G., Rozenblatt, S., & Givol, D. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.150 · Cited by 250
Non-viral gene therapy: Gains and challenges of non-invasive administration methods
Földvári, M., Chen, D.-W., Nafissi, N., Calderon-Nieva, D., Narsineni, L., & Rafiee, A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.012 · Cited by 246
Characterization of CD4+ T Cell Responses During Natural Infection with Salmonella typhimurium
McSorley, S. J., Cookson, B. T., & Jenkins, M. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.986 · Cited by 239
Induced Pluripotent Stem Cells: Problems and Advantages when Applying them in Regenerative Medicine
Medvedev, S. P., Shevchenko, A. I., & Zakian, S. M. (2010) · Acta Naturae · doi:10.32607/20758251-2010-2-2-18-27 · Cited by 234
Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells
Steingen, C., Brenig, F., Baumgartner, L., Schmidt, J., Schmidt, A., & Bloch, W. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.03.010 · Cited by 233
Polycistronic Lentiviral Vector for “Hit and Run” Reprogramming of Adult Skin Fibroblasts to Induced Pluripotent Stem Cells
Chang, C.-W., Lai, Y.-S., Pawlik, K. M., Liu, K.-M., Sun, C.-W., Li, C., Schoeb, T., & Townes, T. (2009) · Stem Cells · doi:10.1002/stem.39 · Cited by 229
Inefficient Reprogramming of Fibroblasts into Cardiomyocytes Using Gata4, Mef2c, and Tbx5
Chen, J., Krane, M., Deutsch, M.-A., Wang, L., Rav-Acha, M., Grégoire, S., Engels, M. C., Rajarajan, K., Karra, R., Abel, E. D., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.270264 · Cited by 228
Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo
Kuhn, A. N., Diken, M., Kreiter, S., Selmi, A., Kowalska, J., Jemielity, J., Darzynkiewicz, E., Huber, C., Türeci, Ö., & Sahin, U. (2010) · Gene Therapy · doi:10.1038/gt.2010.52 · Cited by 226
Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals
Kreiter, S., Selmi, A., Diken, M., Sebastian, M., Osterloh, P., Schild, H., Huber, C., Türeci, Ö., & Şahin, U. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.309 · Cited by 221
Modified mRNA Vaccines Protect against Zika Virus Infection
Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.016 · Cited by 221
mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation
Levy, O., Zhao, W., Mortensen, L. J., LeBlanc, S., Tsang, K., Fu, M., Phillips, J. A., Sagar, V., Anandakumaran, P. N., Ngai, J., et al. (2013) · Blood · doi:10.1182/blood-2013-04-495119 · Cited by 212
Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: Key regulators of innate immunity
Barral, P. M., Sarkar, D., Su, Z.-Z., Barber, G. N., DeSalle, R., Racaniello, V. R., & Fisher, P. B. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.012 · Cited by 201
Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow
Xia, L., McDaniel, J. M., Yago, T., Doeden, A., & McEver, R. P. (2004) · Blood · doi:10.1182/blood-2004-02-0650 · Cited by 199
Comprehensive Analysis of Chemotactic Factors for Bone Marrow Mesenchymal Stem Cells
Ozaki, Y., Nishimura, M., Sekiya, K., Suehiro, F., Kanawa, M., Nikawa, H., Hamada, T., & Kato, Y. (2007) · Stem Cells and Development · doi:10.1089/scd.2006.0032 · Cited by 198
Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo
Kauffman, K. J., Mir, F. F., Jhunjhunwala, S., Kaczmarek, J. C., Hurtado, J. E., Yang, J. H., Webber, M. J., Kowalski, P. S., Heartlein, M. W., DeRosa, F., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.006 · Cited by 195
Systematic discovery of structural elements governing stability of mammalian messenger RNAs
Goodarzi, H., Najafabadi, H. S., Oikonomou, P., Greco, T. M., Fish, L., Salavati, R., Cristea, I. M., & Tavazoie, S. (2012) · Nature · doi:10.1038/nature11013 · Cited by 187
Engineering of Therapeutic Proteins Production in Escherichia coli
Kamionka, M. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111794295693 · Cited by 179
Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation
Zhang, M., Lin, Y.-H., Sun, Y. J., Zhu, S., Zheng, J., Liu, K., Cao, N., Li, K., Huang, Y., & Ding, S. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.03.020 · Cited by 178
High affinity interaction of integrin α4β1 (VLA‐4) and vascular cell adhesion molecule 1 (VCAM‐1) enhances migration of human melanoma cells across activated endothelial cell layers
Klemke, M., Weschenfelder, T., Konstandin, M. H., & Samstag, Y. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21029 · Cited by 167
mRNA transfection of dendritic cells: Synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level
Mockey, M., Gonçalves, C., Dupuy, F. P., Lemoine, F. M., Pichon, C., & Midoux, P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.105 · Cited by 165
Rapid Conversion of Fibroblasts into Functional Forebrain GABAergic Interneurons by Direct Genetic Reprogramming
Colasante, G., Lignani, G., Rubio, A., Medrihan, L., Yekhlef, L., Sessa, A., Massimino, L., Giannelli, S. G., Sacchetti, S., Caiazzo, M., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.09.002 · Cited by 165
Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells
Scholten, K. B. J., Kramer, D., Taanman-Kueter, E. W., Graf, M., Schoedl, T., Meijer, C. J. L. M., Schreurs, M. W. J., & Hooijberg, E. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.12.009 · Cited by 164
Recombinant therapeutic proteins: Production platforms and challenges
Dingermann, T. (2007) · Biotechnology Journal · doi:10.1002/biot.200700214 · Cited by 164
Clinical efficacy of becaplermin (rhPDGF-BB) gel
Wieman, T. J. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00185-8 · Cited by 162
Recombinant human platelet‐derived growth factor‐BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open‐label clinical evaluation of efficacy
Embil, J. M., Papp, K. A., Sibbald, G. R., Tousignant, J., Smiell, J. M., Wong, B. Y. L., Lau, C., & THE CANADIAN BECAPLERMIN STUDY GROUP (2000) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2000.00162.x · Cited by 161
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system
DeRosa, F., Guild, B., Karve, S., Smith, L., Love, K., Dorkin, J. R., Kauffman, K. J., Zhang, J., Yahalom, B., Anderson, D. G., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.46 · Cited by 159
[4] Synthesis of long, capped transcripts in Vitro by SP6 and T7 RNA polymerases
Yisraeli, J. K., & Melton, D. A. (1989) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(89)80090-4 · Cited by 156
Effects of Chemically Modified Messenger RNA on Protein Expression
Li, B., Luo, X. L., & Dong, Y. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00090 · Cited by 154
Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells
Grudzien‐Nogalska, E., Jemielity, J., Kowalska, J., Darżynkiewicz, E., & Rhoads, R. E. (2007) · RNA · doi:10.1261/rna.701307 · Cited by 152
Gene Therapy of Intracranial Glioma Using Interleukin 12–Secreting Human Umbilical Cord Blood–Derived Mesenchymal Stem Cells
Ryu, C. H., Park, S., Park, S. A., Kim, S. M., Lim, J. Y., Jeong, C. H., Yoon, W., Oh, W., Sung, Y. C., & Jeun, S. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.187 · Cited by 151
Reverse 5' caps in RNAs made in vitro by phage RNA polymerases.
Pasquinelli, A. E., Dahlberg, J. E., & Lund, E. (1995) · PubMed · Cited by 148
Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine
Nakanishi, M., & Otsu, M. (2012) · Current Gene Therapy · doi:10.2174/156652312802762518 · Cited by 147
Regulation of mRNA decapping
Li, Y., & Kiledjian, M. (2010) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.15 · Cited by 145
Rapid, nondenaturing RNA purification using weak anion-exchange fast performance liquid chromatography
Easton, L. E., Shibata, Y., & Lukavsky, P. J. (2010) · RNA · doi:10.1261/rna.1862210 · Cited by 143
Function and Regulation of Retinoic Acid-Inducible Gene-I
Matsumiya, T., & Stafforini, D. M. (2010) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v30.i6.10 · Cited by 140
Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia
Nabhan, J. F., Wood, K. M., Rao, V. P., Morin, J., Bhamidipaty, S., LaBranche, T. P., Gooch, R. L., Bozal, F., Bulawa, C. E., & Guild, B. C. (2016) · Scientific Reports · doi:10.1038/srep20019 · Cited by 140
Cap-Independent Translation Conferred by the 5′ Leader of Tobacco Etch Virus Is Eukaryotic Initiation Factor 4G Dependent
Gallie, D. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12141-12152.2001 · Cited by 134
Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model
Kyriakou, C. A., Rabin, N. K., Pizzey, A. R., Nathwani, A. C., & Yong, K. (2008) · Haematologica · doi:10.3324/haematol.12553 · Cited by 130
Decoying the Cap 2 mRNA Degradation System by a Double-Stranded RNA Virus and Poly(A) 2 mRNA Surveillance by a Yeast Antiviral System
Masison, D. C., Blanc, A., Ribas, J. C., Carroll, K., Sonenberg, N., & Wickner, R. B. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2763 · Cited by 128
Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model
Ling, X., Marini, F. C., Konopleva, M. Y., Schober, W. D., Shi, Y., Burks, J. K., Clise-Dwyer, K., Wang, R., Zhang, W., Yuan, X., et al. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0041-8 · Cited by 122
A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
Kallen, K., & Theß, A. (2013) · Therapeutic Advances in Vaccines · doi:10.1177/2051013613508729 · Cited by 122
Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy
Zaruba, M., & Franz, W. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903460286 · Cited by 121
Protein Therapeutics for Cardiac Regeneration after Myocardial Infarction
Segers, V. F. M., & Lee, R. T. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9207-5 · Cited by 121
Reprogramming of pancreatic exocrine cells towards a beta (β) cell character using Pdx1, Ngn3 and MafA
Akıncı, E., Banga, A., Greder, L. V., Dutton, J. R., & Slack, J. M. W. (2011) · Biochemical Journal · doi:10.1042/bj20111678 · Cited by 118
Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy
Youn, H., & Chung, J.-K. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1057563 · Cited by 114
Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells
Choi, H. Y., Lee, T., Yang, G., Oh, J., Won, J., Han, J., Jeong, G., Kim, J., Kim, J., Kim, B., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.007 · Cited by 114
Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism
Mays, L. E., Ammon-Treiber, S., Mothes, B., Alkhaled, M., Rottenberger, J., Müller-Hermelink, E. S., Grimm, M., Mezger, M., Beer-Hammer, S., von Stebut, E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65351 · Cited by 113
RNA Mediated toll-like receptor stimulation in health and disease
Dalpke, A. H., & Helm, M. (2012) · RNA Biology · doi:10.4161/rna.20206 · Cited by 113
Structural and biochemical studies of the 5′→3′ exoribonuclease Xrn1
Chang, J. H., Xiang, S., Xiang, K., Manley, J. L., & Tong, L. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1984 · Cited by 113
The Poly(A)-Binding Protein and an mRNA Stability Protein Jointly Regulate an Endoribonuclease Activity
Wang, Z., & Kiledjian, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.17.6334-6341.2000 · Cited by 113
Messenger RNA-based therapeutics for brain diseases: An animal study for augmenting clearance of beta-amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles
Lin, C., Perche, F., Ikegami, M., Uchida, S., Kataoka, K., & Itaka, K. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.001 · Cited by 113
Cardiac regeneration: current therapies-future concepts.
Doppler, S. A., Deutsch, M.-A., Lange, R., & Krane, M. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2013.08.71 · Cited by 112
The CCR2/CCL2 Interaction Mediates the Transendothelial Recruitment of Intravascularly Delivered Neural Stem Cells to the Ischemic Brain
Andres, R. H., Choi, R., Pendharkar, A. V., Gaeta, X., Wang, N. N., Nathan, J. K., Chua, J. Y., Lee, S. W., Palmer, T. D., Steinberg, G. K., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.606368 · Cited by 108
Adenoviral‐mediated interleukin‐18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats
Xu, G., Jiang, X., Xu, Y., Zhang, J., Huang, F., Chen, Z., Zhou, D., Shang, J., Zou, Y., Cai, Y., et al. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2008.07.023 · Cited by 108
A Nucleolin-Binding 3′ Untranslated Region Element Stabilizes β-Globin mRNA In Vivo
Jiang, Y., Xu, X.-S., & Russell, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2419-2429.2006 · Cited by 104
Functions of the 5′‐terminal m7G cap in eukaryotic mRNA
Filipowicz, W. (1978) · FEBS Letters · doi:10.1016/0014-5793(78)81049-7 · Cited by 102
Denaturing Urea Polyacrylamide Gel Electrophoresis (Urea PAGE)
Summer, H., Grämer, R., & Dröge, P. (2009) · Journal of Visualized Experiments · doi:10.3791/1485 · Cited by 102
Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis
Liao, W., Pham, V., Liu, L., Riazifar, M., Pone, E. J., Zhang, S. X., Ma, F., Lu, M., Walsh, C. M., & Zhao, W. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.005 · Cited by 102
Restoration of Bone Mass and Strength in Glucocorticoid-Treated Mice by Systemic Transplantation of CXCR4 and Cbfa-1 Co-Expressing Mesenchymal Stem Cells
Lien, C.-Y., Ho, K., Lee, O. K., Blunn, G. W., & Su, Y. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081257 · Cited by 100
mRNA-based gene transfer as a tool for gene and cell therapy.
Tendeloo, V. F. V., Ponsaerts, P., & Berneman, Z. N. (2007) · PubMed · Cited by 98
TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo
Mueller, L. P., Luetzkendorf, J., Widder, M., Nerger, K., Caysa, H., & Mueller, T. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.68 · Cited by 98
Purification and characterization of transcribed RNAs using gel filtration chromatography
McKenna, S. A., Kim, I., Puglisi, E. V., Lindhout, D. A., Aitken, C. E., Marshall, R. A., & Puglisi, J. D. (2007) · Nature Protocols · doi:10.1038/nprot.2007.480 · Cited by 98
Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise
Duelen, R., & Sampaolesi, M. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.029 · Cited by 97
Differential Inhibition of mRNA Degradation Pathways by Novel Cap Analogs
Grudzien, E., Kalek, M., Jemielity, J., Darzynkiewicz, E., & Rhoads, R. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509121200 · Cited by 90
Structural and Functional Analysis of an mRNP Complex That Mediates the High Stability of Human β-Globin mRNA
Yu, J., & Russell, J. E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5879-5888.2001 · Cited by 90
Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity
Uchida, S., Kataoka, K., & Itaka, K. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7030137 · Cited by 90
Oligodeoxynucleotides Differentially Modulate Activation of TLR7 and TLR8 by Imidazoquinolines
Gorden, K. B., Qiu, X., Battiste, J. L., Wightman, P. D., Vasilakos, J. P., & Alkan, Ş. Ş. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8164 · Cited by 90
Characterization of Coding Synonymous and Non-Synonymous Variants in ADAMTS13 Using Ex Vivo and In Silico Approaches
Edwards, N. C., Hing, Z. A., Perry, A., Blaisdell, A., Kopelman, D., Fathke, R. L., Plum, W. G., Newell, J. M., Allen, C. E., Geetha, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038864 · Cited by 87
MSC-based VEGF gene therapy in rat myocardial infarction model using facial amphipathic bile acid-conjugated polyethyleneimine
Moon, H.-H., Joo, M. K., Mok, H., Lee, M., Hwang, K.-C., Kim, S. W., Jeong, J. H., Choi, D., & Kim, S. H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.019 · Cited by 84
Dedifferentiation, Transdifferentiation, and Reprogramming: Future Directions in Regenerative Medicine
Eguizábal, C., Montserrat, N., Veiga, A., & Belmonte, J. C. I. (2013) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1331802 · Cited by 83
Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells
Bontkes, H. J., Kramer, D., Ruizendaal, J. J., Taanman-Kueter, E. W., Tendeloo, V. F. V., Meijer, C. J. L. M., & Hooijberg, E. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302874 · Cited by 82
Virus-inspired nucleic acid delivery system: Linking virus and viral mimicry
Ni, R., Zhou, J., Hossain, N., & Chau, Y. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.005 · Cited by 82
A Comparative Study of the Bone Regenerative Effect of Chemically Modified RNA Encoding BMP-2 or BMP-9
Khorsand, B., Elangovan, S., Hong, L., Dewerth, A., Kormann, M., & Salem, A. K. (2017) · The AAPS Journal · doi:10.1208/s12248-016-0034-8 · Cited by 82
Myotonic Dystrophy: The Role of RNA CUG Triplet Repeats
Timchenko, L. (1999) · The American Journal of Human Genetics · doi:10.1086/302268 · Cited by 81
Regeneration of bone using nanoplex delivery of FGF-2 and BMP-2 genes in diaphyseal long bone radial defects in a diabetic rabbit model
Khorsand, B., Nicholson, N., Do, A., Femino, J. E., Martin, J. A., Petersen, E. B., Guetschow, B., Fredericks, D. C., & Salem, A. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.008 · Cited by 81
Synthesis and Application of a Chain-Terminating Dinucleotide mRNA Cap Analog
Peng, Z., Sharma, V., Singleton, S. F., & Gershon, P. D. (2001) · Organic Letters · doi:10.1021/ol0167715 · Cited by 80
Targeted delivery of progenitor cells for cartilage repair
Dennis, J. E., Cohen, N., Goldberg, V. M., & Caplan, A. I. (2004) · Journal of Orthopaedic Research® · doi:10.1016/j.orthres.2003.12.002 · Cited by 80
Characterization of T‐cell immune responses of Echinococcus multilocularis‐infected C57BL/6J mice
Emery, I., Liance, M., Dériaud, E., Vuitton, D. A., Houin, R., & Leclerc, C. (1996) · Parasite Immunology · doi:10.1111/j.1365-3024.1996.tb01030.x · Cited by 80
Transcript-activated collagen matrix as sustained mRNA delivery system for bone regeneration
Badieyan, Z. S., Berezhanskyy, T., Utzinger, M., Aneja, M. K., Emrich, D., Erben, R. G., Schüler, C., Altpeter, P., Ferizi, M., Hasenpusch, G., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.037 · Cited by 80
Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges
Steinle, H., Behring, A., Schlensak, C., Wendel, H. P., & Avci‐Adali, M. (2016) · Stem Cells · doi:10.1002/stem.2402 · Cited by 78
Expression of human nephrin mRNA in diabetic nephropathy
Toyoda, M. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg545 · Cited by 77
Apoptosis and the cardiac action of insulin-like growth factor I
Suleiman, M. S., Singh, R. B., & Stewart, C. E. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.001 · Cited by 75
Analysis of oligonucleotide AUG start codon context in eukariotic mRNAs
Pesole, G., Gissi, C., Grillo, G., Licciulli, F., Liuni, S., & Saccone, C. (2000) · Gene · doi:10.1016/s0378-1119(00)00471-6 · Cited by 74
Recent Advances in Developing Small Molecules Targeting Nucleic Acid
Wang, M., Yu, Y., Liang, C., Lü, A., & Zhang, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060779 · Cited by 74
Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond
Vallazza, B., Petri, S., Poleganov, M. A., Eberle, F., Kuhn, A. N., & Şahin, U. (2015) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1288 · Cited by 73
Synthetic Messenger RNA as a Tool for Gene Therapy
Rabinovich, P. M., Komarovskaya, M., Ye, Z.-J., Imai, C., Campana, D., Bahceci, E., & Weissman, S. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1027 · Cited by 73
Effective delivery with enhanced translational activity synergistically accelerates mRNA-based transfection
Zohra, F. T., Chowdhury, E. H., Tada, S., Hoshiba, T., & Akaike, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.059 · Cited by 71
Synthetic Chemically Modified mRNA-Based Delivery of Cytoprotective Factor Promotes Early Cardiomyocyte Survival Post-Acute Myocardial Infarction
Huang, C., Leblond, A., Turner, E. C., Kumar, A. H. S., Martin, K., Whelan, D., O’Sullivan, D. M., & Caplice, N. M. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5006239 · Cited by 70
UU/UA Dinucleotide Frequency Reduction in Coding Regions Results in Increased mRNA Stability and Protein Expression
Al‐Saif, M., & Khabar, K. S. A. (2012) · Molecular Therapy · doi:10.1038/mt.2012.29 · Cited by 69
Non-viral nucleic acid delivery methods
Slivac, I., Guay, D. R. P., Mangion, M., Champeil, J., & Gaillet, B. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1248941 · Cited by 69
Cystic fibrosis transmembrane conductance regulator‐mRNA delivery: a novel alternative for cystic fibrosis gene therapy
Bangel‐Ruland, N., Tomczak, K., Fernández, E. F., Leier, G., Leciejewski, B., Rudolph, C., Rosenecker, J., & Weber, W. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2748 · Cited by 67
Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins
Gulck, E. R. A. V. (2005) · Blood · doi:10.1182/blood-2005-01-0339 · Cited by 64
The Pharmacology of Regenerative Medicine
Christ, G. J., Saul, J. M., Furth, M. E., & Andersson, K. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007393 · Cited by 63
Non-Viral Methods For Generating Integration-Free, Induced Pluripotent Stem Cells
Deng, X., Wang, H., Wang, T., Fang, X.-T., Zou, L., Li, Z., & Liu, C.-B. (2015) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x09666140923101914 · Cited by 62
Modified mRNA for BMP-2 in Combination with Biomaterials Serves as a Transcript-Activated Matrix for Effectively Inducing Osteogenic Pathways in Stem Cells
Balmayor, E. R., Geiger, J. P., Koch, C., Aneja, M. K., van Griensven, M., Rudolph, C., & Plank, C. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0171 · Cited by 62
Neural Stem Cells Differentiated From iPS Cells Spontaneously Regain Pluripotency
Choi, H. W., Kim, J. S., Choi, S., Hong, Y. J., Kim, M. J., Seo, H. G., & Tae, J. (2014) · Stem Cells · doi:10.1002/stem.1757 · Cited by 61
Self-citation
Polysaccharide Multilayer Nanoencapsulation of Insulin-Producing β-Cells Grown as Pseudoislets for Potential Cellular Delivery of Insulin
Zhi, Z., Liu, B., Jones, P. M., & Pickup, J. C. (2010) · Biomacromolecules · doi:10.1021/bm901152k · Cited by 61
Improved Methods to Produce Tissue-Engineered Skin Substitutes Suitable for the Permanent Closure of Full-Thickness Skin Injuries
Larouche, D., Cantin-Warren, L., Desgagné, M., Guignard, R., Martel, I., Ayoub, A., Lavoie, A., Gauvin, R., Auger, F. A., Moulin, V. J., et al. (2016) · BioResearch open access · doi:10.1089/biores.2016.0036 · Cited by 61
Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion
Tcherepanova, I. Y., Adams, M. D., Feng, X., Hinohara, A., Horvatinovich, J. M., Calderhead, D. M., Healey, D. G., & Nicolette, C. A. (2008) · BMC Molecular Biology · doi:10.1186/1471-2199-9-90 · Cited by 60
Synthesis and properties of mRNA cap analogs containing imidodiphosphate moiety—fairly mimicking natural cap structure, yet resistant to enzymatic hydrolysis
Rydzik, A. M., Kulis, M., Łukaszewicz, M., Kowalska, J., Zuberek, J., Darżynkiewicz, Z. M., Darżynkiewicz, E., & Jemielity, J. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.01.013 · Cited by 59
Preparation of Chemically Modified RNA Origami Nanostructures
Endo, M., Takeuchi, Y., Emura, T., Hidaka, K., & Sugiyama, H. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201404084 · Cited by 58
Applications of Phosphate Modification and Labeling to Study (m)RNA Caps
Warmiński, M., Sikorski, P. J., Kowalska, J., & Jemielity, J. (2017) · Topics in Current Chemistry · doi:10.1007/s41061-017-0106-y · Cited by 57
Cell Replacement Strategies Aimed at Reconstitution of the β-Cell Compartment in Type 1 Diabetes
Orlando, G., Gianello, P., Salvatori, M., Stratta, R. J., Söker, S., Ricordi, C., & Domínguez‐Bendala, J. (2014) · Diabetes · doi:10.2337/db13-1742 · Cited by 56
Characterization of T Cell Responses to Fragrances
Sieben, S., Hertl, M., Masaoudi, T. A., Merk, H. F., & Blömeke, B. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9125 · Cited by 55
Synthetic dinucleotide mRNA cap analogs with tetraphosphate 5′,5′ bridge containing methylenebis(phosphonate) modification
Rydzik, A. M., Łukaszewicz, M., Zuberek, J., Kowalska, J., Darżynkiewicz, Z. M., Darżynkiewicz, E., & Jemielity, J. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b911347a · Cited by 55
Peptide-enhanced mRNA transfection in cultured mouse cardiac fibroblasts and direct reprogramming towards cardiomyocyte-like cells
Murthy, N., Lee, K., Yu, P., Lingampalli, N., Kim, H. J., & Tang, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s75124 · Cited by 53
Self-citation
Structurally Distinct Requirements for Binding of P-selectin Glycoprotein Ligand-1 and Sialyl Lewis x to Anaplasma phagocytophilum and P-selectin
Yago, T., Leppänen, A., Carlyon, J. A., Akkoyunlu, M., Karmakar, S., Fikrig, E., Cummings, R. D., & McEver, R. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305778200 · Cited by 53
mRNA: A Versatile Molecule for Cancer Vaccines
Diken, M., Kranz, L. M., Kreiter, S., & Şahin, U. (2016) · Current Issues in Molecular Biology · doi:10.21775/cimb.022.113 · Cited by 52
Enzymatically stable 5′ mRNA cap analogs: Synthesis and binding studies with human DcpS decapping enzyme
Kałek, M., Jemielity, J., Darżynkiewicz, Z. M., Bojarska, E., Stȩpiński, J., Stolarski, R., Davis, R. E., & Darżynkiewicz, E. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.045 · Cited by 50
Self-assembled Messenger RNA Nanoparticles (mRNA-NPs) for Efficient Gene Expression
Kim, H., Park, Y., & Lee, J. B. (2015) · Scientific Reports · doi:10.1038/srep12737 · Cited by 50
Antisense ribosomes: rRNA as a vehicle for antisense RNAs.
Sweeney, R., Fan, Q., & Yao, M. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8518 · Cited by 49
New strategies for improving stem cell therapy in ischemic heart disease
Huang, P., Tian, X., Li, Q., & Yang, Y. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9576-1 · Cited by 47
Recent Trends in Drug Delivery System Using Protein Nanoparticles
Sripriyalakshmi, S., Jose, P., Ravindran, A., & Anjali, C. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-9896-5 · Cited by 46
Design of an Optimized Wilms’ Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo
Benteyn, D., Anguille, S., Lint, S. V., Heirman, C., Nuffel, A. M. T. V., Corthals, J., Ochsenreither, S., Waelput, W., Beneden, K. V., Breckpot, K., et al. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.54 · Cited by 44
Characterization of T Cell Responses to Hev b 3, an Allergen Associated with Latex Allergy in Spina Bifida Patients
Bohle, B., Wagner, B., Vollmann, U., Buck, D., Niggemann, B., Szépfalusi, Z., Fischer, G., Scheiner, O., Breiteneder, H., & Ebner, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4393 · Cited by 43
Therapeutic Modulation of Growth Factors and Cytokines in Regenerative Medicine
Ioannidou, E. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777699007 · Cited by 43
Strong anion-exchange fast performance liquid chromatography as a versatile tool for preparation and purification of RNA produced by in vitro transcription
Koubek, J., Lin, K. F., Chen, Y., Cheng, R. P., & Huang, J. J. (2013) · RNA · doi:10.1261/rna.038117.113 · Cited by 43
Towards mRNA with superior translational activity: synthesis and properties of ARCA tetraphosphates with single phosphorothioate modifications
Strenkowska, M., Kowalska, J., Łukaszewicz, M., Zuberek, J., Su, W., Rhoads, R. E., Darżynkiewicz, E., & Jemielity, J. (2010) · New Journal of Chemistry · doi:10.1039/b9nj00644c · Cited by 42
Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage
Sridhar, A., Ohlemacher, S. K., Langer, K. B., & Meyer, J. S. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0093 · Cited by 42
Transcription factor‐mediated reprogramming toward hematopoietic stem cells
Ebina, W., & Rossi, D. J. (2015) · The EMBO Journal · doi:10.15252/embj.201490804 · Cited by 41
Non‐Viral Co‐Delivery of the Four Yamanaka Factors for Generation of Human Induced Pluripotent Stem Cells via Calcium Phosphate Nanocomposite Particles
Cao, X., Deng, W., Qu, R., Yu, Q., Li, J., Yang, Y., Cao, Y., Gao, X., Xu, X., & Yu, J. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201203646 · Cited by 40

Research works printed but not linked: 1

Hartmann, 2007, Triphosphate-RNA is the ligand for the cytosolic receptor retinoic-acid inducible gene-1 (RIG-I), Inflamm. Res., 56, S328

Sorted by citations

mRNA-based therapeutics: powerful and versatile tools to combat diseases
Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01007-w · Cited by 852
RNA-based therapeutics: an overview and prospectus
Zhu, Y., Zhu, L., Wang, X., & Jin, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05075-2 · Cited by 683
Advances in COVID-19 mRNA vaccine development
Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601
mRNA vaccines manufacturing: challenges and bottlenecks
Rosa, S. S., Prazeres, D. M. F., Azevedo, A. M., & Marques, M. P. C. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.03.038 · Cited by 545
Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
Zhang, F., Parayath, N. N., Ene, C., Stephan, S. B., Koehne, A. L., Coon, M. E., Holland, E. C., & Stephan, M. T. (2019) · Nature Communications · doi:10.1038/s41467-019-11911-5 · Cited by 527

See all 208

Authors: Kwon, H., Kim, M., Seo, Y., Moon, Y. S., Lee, H. J., Lee, K., & Lee, H.
Affiliations: Ewha Womans University (KR)
Corresponding author: Lee, Kyuri
Lee, Hyukjin
ORCID: Kim, Minjeong
Lee, Hwa Jeong
Venue: Biomaterials
Publisher: Elsevier BV
Published: 2018-02
Volume: 156
Pages: 172-193
ISSN: 0142-9612 (ISSN-L)
DOI: 10.1016/j.biomaterials.2017.11.034
OpenAlex: W2769785887
Cited by: 208
References: 257
Citations by year: 2026: 17 · 2025: 40 · 2024: 32 · 2023: 43 · 2022: 30 · 2021: 19 · 2020: 14 · 2019: 9 · 2018: 4
FWCI: 0.69
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Biomaterials (publishedVersion)
PubMed (publishedVersion)
Funders: National Research Foundation of Korea
Ministry of Science, ICT and Future Planning (2014M3C1A3054153)
GiRC Program (2012K1A1A2A01056092)
Basic Science Research Program (2015R1A1A1A05027352)
BioMedical Technology Development Program (2015M3A9D7031026)
Ministry of Education (2017R1D1A1B03028278)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords: synthetic mRNA, in vitro transcription, regenerative medicine, mRNA design, cellular reprogramming, stem cell engineering, protein replacement therapy, nucleic acid therapeutics
MeSH terms: Animals, DNA, Humans, Plasmids, RNA, Messenger, Stem Cells, Regenerative Medicine, Cell Engineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks